Company Name: Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc. is engaged in the development of antibacterial therapeutics using tetracycline chemistry. The company’s lead product candidate is a broad spectrum antibiotic designed as an empiric monotherapy for serious community acquired bacterial infections.

Ticker Symbol: PRTK (NASDAQ)

Company Website: www.paratekpharm.com

Social Media:

Paratek Pharmaceuticals LinkedIn

Paratek Pharmaceuticals Twitter

Headquarters: Boston, MA